Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

A New Diagnostic Tool for Fibromyalgia?

  |  

Another benefit of this study method is convenience. Dr. Hackshaw says, “Our studies don’t require patients to abstain from any medications, and there is no stimulation of the blood sample to enhance or diminish cellular activity.”

To move this testing approach closer to the point of care, Dr. Hackshaw and his team are collecting more samples to assess reproducibility. They are also embarking on additional studies of this testing in hopes it will aid rheumatologists and their patients in the future.

ADVERTISEMENT
SCROLL TO CONTINUE

Carina Stanton is a freelance science journalist based in Denver.

References

ADVERTISEMENT
SCROLL TO CONTINUE
  1. Silverman S, Dukes EM, Johnston SS, et al. The economic burden of fibromyalgia: Comparative analysis with rheumatoid arthritis. Curr Med Res Opin. 2009 Apr;25(4):829–840.
  2. Smith HS, Harris R, Clauw D. Fibromyalgia: An afferent processing disorder leading to a complex pain generalized syndrome. Pain Physician. 2011 Mar–Apr;14(2):E217–E245.
  3. Yunus, MB. Central sensitivity syndromes: A new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease vs. illness. Semin Arthritis Rheum. 2008 Jun;37(6):339–352.
  4. Hackshaw KV, Avkas DP, Sigurdson GT, et al. Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders. J Biol Chem. 2019 Feb 15;294(7):2555–2568.

Related Articles

    Revising Fibromyalgia: One Year Later

    The 2010 ACR fibromyalgia criteria capture the broader clinical picture and help ensure more appropriate diagnosis and management by primary care

    Is Fibromyalgia Overdiagnosed?

    Are too many patients diagnosed with fibromyalgia? The co-authors of one new study believe that close to 75% of patients who have received a clinical fibromyalgia diagnosis do not meet the 2010 Preliminary American College of Rheumatology (ACR) Criteria for Fibromyalgia.1 They say these patients are false-positive and may be taking treatments they don’t need….

    Diagnosing & Caring for Patients with Fibromyalgia

    Doebl et al. compared the effect of symptoms and the healthcare use of people with fibromyalgia with those who fulfilled the criteria for fibromyalgia but had not been diagnosed and those with chronic pain. They found patients diagnosed with fibromyalgia reported the poorest healthcare experiences and were more likely than other study participants to be unemployed due to health issues. Their findings reveal an urgent need exists for a model of care for patients with fibromyalgia.

    Treat-to-Target Strategy Evaluated for Fibromyalgia Care

    Treat-to-target is a widely used approach for rheumatoid arthritis, in which rheumatologists prescribe treatments to reach established benchmarks of disease activity.1 Is it time for a similar approach for fibro­myalgia treatment, even though its pathogenesis, disease-activity measures and treatment algorithms are less well understood? Three fibromyalgia researchers present their case in a new paper, “Treat-to-Target…